Results presented in Supporting Information Fig. 3 show that the polyclonal anti-EBI3 Ab is specific for EBI3. The monoclonal Ab against p35 (clone27537), IL-12p40 (mAb609), IL-12p70 (mAb611), IL-27 (mAb25261), and TGF-β (mAb240) were purchased from R&D Systems. The neutralizing polyclonal anti–IL-10 Ab (PAL-hIL10) was obtained from Strathmann Biotech (Hannover, Germany). MAb EB-I against IFN-α
was kindly provided by G. Adolf (Boehringer Ingelheim). PBMC were isolated from buffy coats obtained from the Red Cross in Austria. Heparinized whole blood of healthy donors was separated by standard density gradient centrifugation with Ficoll-PaqueTM Plus (GE Healthcare Chalfont St. Giles, UK). Subsequently, T cells (total-CD3+ T cells used unless stated otherwise), CD4+, CD8+ Tigecycline purchase and CD25– T cells, and monocytes were separated by magnetic sorting using the MACS technique (Miltenyi Biotec, Bergisch Gladbach, Germany) as described previously JAK assay 34. Naïve T cells were isolated from CB. CB samples from healthy
donors were collected during healthy full-term deliveries. Approval was obtained from the Medical University of Vienna institutional review board for these studies. CB-T cells used in this study were CD45RA+ (92±3%) and CD45RO−. DC were generated by culturing purified blood monocytes for 7 days with a combination of GM-CSF (50 ng/mL) and IL-4 (100 U/mL). Preparation and purification of rhinoviruses were performed as described 34. DC were treated with HRV14 for 1 day (R-DC) at a titer of 1 TCID50 (50% tissue culture infectious
dose) per cell. To examine the suppressor activity of the SN of R-DC-induced Treg, T cells were added to R-DC or DC in a 10:1 or 5:1/T-cell:DC ratio. These SN were harvested after 1–3 days of coculture and 100 μL/well were added to different MLR. Centricon YM-50 filters (Millipore, Bedford, MA, USA) were used for size fractionation of the SN. The fraction containing molecules >50 kDa was compared to the fraction containing molecules <50 kDa in an allogeneic MLR. The T cells of the coculture were also investigated by intracellular staining or analyzed via real-time PCR. For the MLR, allogeneic, purified T cells (1×105) were incubated with graded numbers of DC. Experiments were performed in Interleukin-2 receptor 96-well round bottom cell culture plates in RPMI 1640 medium supplemented with 10% FBS. Proliferation of T cells was monitored by measuring (methyl-3H)TdR (ICN Pharmaceuticals, Irvine, CA, USA) incorporation on day 5 of culture. Cells were harvested 18 h later, and radioactivity was determined on a microplate scintillation counter (Packard Instruments, Meriden, CT, USA). Assays were performed in triplicates. For Fig. 1 preactivated T cells were harvested, irradiated (30 Gy, 137Cs source) and tested for their suppressive function, for Supporting Information Fig. 1 and 4A preactivated T cells were not irradiated.